| Serial Number | 79115013 |
| Word Mark | THIOLOGICS |
| Filing Date | Friday, January 27, 2012 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Thursday, January 27, 2022 |
| Registration Number | 4452854 |
| Registration Date | Tuesday, December 24, 2013 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 8, 2013 |
| Goods and Services | Pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic preparations for medical purposes; diagnostic preparations for scientific or research use; diagnostic kits consisting primarily of antibody preparations, namely, antibody bioconjugates, namely, antibody-drug conjugates, antibody-radionuclide conjugates and antibody-imaging agent conjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans |
| Pseudo Mark | THIO LOGICS |
| Goods and Services | Chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, and radionuclides for medical applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in medical research; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of disease |
| Goods and Services | Scientific and technological services, namely, design and assembly of polypeptide bioconjugates and polynucleic acid bioconjugates, and design and optimization of proprietary bioconjugation technologies; biological research; chemical research and analysis; scientific advisory services relating to research and development in the field of diagnostic preparations and diagnostic products; providing scientific information and advisory services in the fields of scientific research and design, and biological and chemical research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 26, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UCL Business plc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | London W1T 4TP GB |
| Party Name | UCL Business plc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London W1T 4TP GB |
| Party Name | UCL Business plc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London W1T 4TP GB |
| Event Date | Event Description |
| Sunday, August 21, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| Sunday, August 21, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| Saturday, January 29, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Thursday, December 23, 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, December 23, 2021 | INVALIDATION PROCESSED |
| Tuesday, October 26, 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Saturday, October 2, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, February 26, 2021 | CANCELLED SECTION 71 |
| Monday, December 24, 2018 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, June 6, 2014 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 19, 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, May 19, 2014 | FINAL DISPOSITION PROCESSED |
| Monday, March 24, 2014 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, December 24, 2013 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 8, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 8, 2013 | PUBLISHED FOR OPPOSITION |
| Monday, October 7, 2013 | NOTIFICATION PROCESSED BY IB |
| Wednesday, September 18, 2013 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 18, 2013 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 18, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 30, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, August 22, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 20, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 20, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 20, 2013 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, March 7, 2013 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, March 7, 2013 | FINAL REFUSAL E-MAILED |
| Thursday, March 7, 2013 | FINAL REFUSAL WRITTEN |
| Thursday, February 14, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 14, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 7, 2013 | ASSIGNED TO LIE |
| Wednesday, February 6, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 30, 2012 | REFUSAL PROCESSED BY IB |
| Tuesday, August 7, 2012 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 7, 2012 | REFUSAL PROCESSED BY MPU |
| Tuesday, August 7, 2012 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, August 7, 2012 | APPLICATION FILING RECEIPT MAILED |
| Monday, August 6, 2012 | NON-FINAL ACTION WRITTEN |
| Friday, August 3, 2012 | ASSIGNED TO EXAMINER |
| Friday, August 3, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 2, 2012 | SN ASSIGNED FOR SECT 66A APPL FROM IB |